Merit Financial Group LLC increased its stake in Lockheed Martin Corporation by 34.2% in Q4, holding 19,776 shares valued at $9.565 million. Lockheed Martin recently secured a $1.9 billion contract for C-130J maintenance and aircrew training and could benefit from proposed increases in U.S. defense spending. Analysts currently have a consensus "Hold" rating on the stock with a target price of $645.79, despite the company missing its Q1 EPS estimate.

Merit Financial Group LLC increased its stake in Thermo Fisher Scientific Inc. by 34%, purchasing an additional 3,934 shares to bring its total holdings to 15,504 shares, valued at nearly $9 million. This move comes as Thermo Fisher has reported strong earnings, exceeding analyst expectations, and maintains a "Moderate Buy" consensus rating from Wall Street with a target price of $631.25. The company also increased its quarterly dividend.

Merit Financial Group LLC increased its stake in UnitedHealth Group Incorporated by 29.1% in the fourth quarter, bringing its total holdings to 33,207 shares valued at approximately $10.96 million. UnitedHealth Group's Q1 earnings surpassed expectations with an EPS of $2.11 and revenue of $113.73 billion, exceeding analyst forecasts. The company maintains a "Moderate Buy" consensus rating with an average target price of $363.42, despite ongoing regulatory risks affecting its Medicare Advantage segment.

Merit Financial Group LLC increased its stake in Union Pacific Corporation (NYSE:UNP) by 11.3% in Q4 2025, now holding 43,455 shares valued at approximately $10.05 million. The railroad operator is set to release its Q1 earnings on April 23, with analysts maintaining a "Moderate Buy" rating and an average price target of $267.48. Union Pacific also pays a quarterly dividend of $1.38, yielding about 2.2% annually.

Nio's sub-brand Onvo has unveiled the exterior features of its updated L90 SUV, set for launch on April 21st. The 2026 L90 will introduce a watchtower-style LiDAR setup, two-tone body color options, and Nio's in-house developed Shenji NX9031 smart driving chip for enhanced autonomous capabilities. This update aims to boost sales in the competitive mass-market EV segment, leveraging advanced technology and design improvements.

Telecom Argentina S.A. (NYSE: TECO, US8792732096) is highlighted as an attractive investment for U.S. and English-speaking investors due to its market dominance in Argentina's telecom sector, offering exposure to Latin America's digital growth. The article details its integrated fixed-mobile business model, strategic initiatives in fiber and 5G, and strong competitive position against rivals. Despite macroeconomic risks like currency volatility, analysts view the stock positively, pointing to its dividend potential and diversification benefits for U.S. portfolios.

Fastenal Co. thrives as a key supplier of fasteners and tools to U.S. manufacturing, offering investors exposure to industrial cycles without heavy manufacturing risks. Its localized vending machine network and managed inventory services differentiate it from competitors, fostering recurring revenue and strong customer relationships. The company's focus on essential supplies and diversification into safety and metalworking products ensure resilience during economic shifts, making it a robust option for investors tracking domestic industrial health.

Mirae Asset Global Investments Co. Ltd. increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 17.7% in the fourth quarter, acquiring an additional 6,572 shares to bring its total holdings to 43,781 shares valued at approximately $29.62 million. This comes as IDEXX Laboratories beat quarterly earnings expectations with $3.08 EPS and $1.09 billion in revenue, and issued strong FY2026 guidance. Despite significant insider selling totaling nearly $30 million over the last quarter, analysts maintain a "Moderate Buy" rating with a consensus target price of $760.

The Williams Cos., Inc. has revised its stock evaluation, currently priced at $70.86, and has significantly outperformed the S&P 500 year-to-date with a 17.88% return compared to the S&P 500's 2.86%. Over the last five years, the company achieved a 200% return, showcasing strong market resilience. Technical indicators show a mixed but generally bullish trend, with the company maintaining a strong position in the oil sector amidst changing market conditions.

Alexandria Real Estate Equities (ARE) specializes in high-quality lab and office space for life sciences, tech, and agtech innovators, offering investors exposure to surging biotech demand through stable rental income and a strong development pipeline. The company's niche focus on state-of-the-art lab campuses in key innovation hubs, backed by long-term leases with high-credit tenants like Moderna and Genentech, drives premium rents and consistent financial growth. ARE's strategic positioning, robust tenant base, and financially sound operations make it an attractive investment for inflation protection and growth in the innovation economy.